Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod
EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,772,907 (the ‘907 Patent) and allowed U.S. Patent Application …
Read More